Letter by Jin-shan and Xue-bin Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)"

被引:0
|
作者
He Jin-shan [1 ]
Li Xue-bin [1 ]
机构
[1] Peking Univ, Peoples Hosp, Dept Cardiol, Beijing Key Lab Early Predict & Intervent Acute M, Beijing, Peoples R China
关键词
D O I
10.1161/CIRCULATIONAHA.117.031407
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:988 / 988
页数:1
相关论文
共 50 条
  • [21] Sodium-glucose cotransporter-2 inhibitors protect against atrial fibrillation in patients with heart failure
    Zhou, Lili
    Yang, Yuanyuan
    Han, Weixing
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (10) : 10887 - 10895
  • [22] Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure With Preserved Ejection Fraction and Type 2 Diabetes
    Fu, Edouard L.
    Patorno, Elisabetta
    Everett, Brendan
    Vaduganathan, Muthiah
    Solomon, Scott
    Levin, Raisa
    Schneeweiss, Sebastian
    Desai, Rishi
    CIRCULATION, 2022, 146
  • [23] COMPARATIVE EFFECTIVENESS OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS AMONG PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: A REAL-WORLD STUDY
    Riaz, M.
    Smith, S.
    Winchester, D. E.
    Guo, J.
    Dietrich, E.
    Park, H.
    VALUE IN HEALTH, 2023, 26 (06) : S23 - S23
  • [24] Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure A Systematic Review and Meta-analysis
    Zou, Xinyu
    Shi, Qingyang
    Vandvik, Per Olav
    Guyatt, Gordon
    Lang, Chim C.
    Parpia, Sameer
    Wang, Si
    Agarwal, Arnav
    Zhou, Yiling
    Zhu, Ye
    Tian, Haoming
    Zhu, Zhiming
    Li, Sheyu
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (06) : 851 - +
  • [25] Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus
    Berg, David D.
    Wiviott, Stephen D.
    Scirica, Benjamin M.
    Gurmu, Yared
    Mosenzon, Ofri
    Murphy, Sabina A.
    Bhatt, Deepak L.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Wilding, John P. H.
    Johanson, Per
    Johansson, Peter A.
    Langkilde, Anna Maria
    Raz, Itamar
    Braunwald, Eugene
    Sabatine, Marc S.
    CIRCULATION, 2019, 140 (19) : 1569 - 1577
  • [26] Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
    Cohen, Laura P. P.
    Isaza, Nicolas
    Hernandez, Inmaculada
    Lewis, Gregory D. D.
    Ho, Jennifer E. E.
    Fonarow, Gregg C. C.
    Kazi, Dhruv S. S.
    Bellows, Brandon K. K.
    JAMA CARDIOLOGY, 2023, 8 (05) : 419 - 428
  • [27] The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure, Regardless of Diabetes Status: Focus on Cardiovascular Disease
    Ferrari, Filipe
    Martins, Vitor M.
    Scheffel, Rafael S.
    da Silveira, Anderson D.
    Motta, Marcelo Trotte
    Moriguchi, Emilio H.
    Santos, Raul D.
    Stein, Ricardo
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (10) : 1267 - 1275
  • [28] Real-Life Individual Comparison of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Heart Failure and Diabetes Mellitus
    Yilmaz, Mehmet Birhan
    Celik, Ahmet
    Colluoglu, Tugce
    Sahin, Anil
    Ural, Dilek
    Kanik, Arzu
    Ata, Naim
    Ulgu, Mustafa Mahir
    Birinci, Suayip
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2025, 25 (02) : 277 - 286
  • [29] Sodium-Glucose Cotransporter-2 Inhibitors: An Old Medication With New Indication in Heart Failure With Preserved Ejection Fraction
    El Hussein, Mohamed Toufic
    Reeves, Cassandra
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2023, 19 (08):
  • [30] Quantitative effects of sodium-glucose cotransporter-2 inhibitors dapagliflozin and empagliflozin on quality of life in heart failure patients
    Wang, Dong-Dong
    Zhang, Cun
    Zhu, Ping
    He, Su-Mei
    Chen, Xiao
    FRONTIERS IN PHARMACOLOGY, 2022, 13